Summary. The effects of increased tissue glycogen stores on insulin sensitivity, and on the response of insulin-stimulated glucose utilisation to an acute elevation in plasma fatty acid levels (-1.5 mmol/1), were investigated in conscious rats using the hyperinsulinaemic euglycaemic clamp. Studies were performed in two groups of rats; (a) fasted 24 h; (b) fasted 4.5 h, but infused with glucose for 4 h (0.5 g/h) of this period before the clamp (fed, glucose infused rats). Clamp glucose requirement and 3-3H-glucose turnover were 20-25% lower in the fed, glucose-infused rats. In these rats, elevation of plasma fatty acid levels resulted in impaired suppression of hepatic glucose output (residual hepatic glucose output: 41 _+ 4 vs 8 + 6 ~tmol. rain-', kg '. p < 0.001) but did not further decrease 3-3H-glucose turnover. Elevated nonesterified fatty acid levels had no significant effect on glucose kinetics in 24 h fasted rats. In the fed glucose-infused rats, at low plasma fatty acid levels, there was no deposition of glycogen in muscle during the clamp and liver glycogen levels fell. With elevation of non-esterified fatty acid levels muscle glycogen deposition was stimulated in both groups, and there was no fall in liver glycogen during the clamps in the fed glucose-infused rats. Increased non-esterified fatty acid availability during the clamps decreased pyruvate dehydrogenase activity in liver, heart, adipose tissue and quadriceps muscle, in both groups of rats. The findings are consistent with an inhibition of glycolysis in liver, skeletal muscle and heart by increased fatty acid availability. Increased glycogen synthesis, however, compensates for decreased glycolytic flux so that glucose turnover is not decreased. When liver glycogen stores are high, an acute increase in non-esterified fatty acid availability impairs suppression of hepatic glucose output. A chronic increase in nou-esteriefid fatty acid availability may lead to insulin resistance by increasing glycogen stores.
Increased availability of non-esterified fatty acids (NEFA) has been suggested as an important cause of insulin resistance and glucose intolerance in obesity and diabetes [1] . The underlying mechanism is believed to be the "glucose-fatty acid cycle" [2] ; in heart and red skeletal muscle, increased fatty acid and ketone body oxidation inhibits glucose oxidation at the level of pyruvate dehydrogenase (PDH) [3] [4] [5] [6] , while glycolysis is inhibited at the level of phosphofructokinase [7] [8] [9] . Inhibition of flux through phosphofructokinase increases glucose-6-phosphate concentrations and thus inhibits muscle hexokinase and glucose uptake [2] .
Since skeletal muscle and liver are quantitatively the most important tissues for disposal of an oral glucose load [10, 11] the glucose-fatty acid cycle must operate in these tissues if it is to explain insulin resistance and glucose intolerance. However, in contrast to the impaired glucose utilisation accompanying a chronic elevation in plasma NEFA, as occurs in starvation [12, 13] and in rats fed a high fat diet [14] [15] [16] [17] , an acute increase in NEFA availability does not consistently impair glucose utilisation by resting skeletal muscle [18] [19] [20] [21] [22] [23] . The effects of an acute increase in NEFA levels on hepatic glucose metabolism are also controversial. Thus, in man and rats insulin-mediated suppression of hepatic glucose production during a glucose clamp has been reported to be unchanged [23, 24] or impaired [22] by increased NEFA availability.
The failure of an acute increase in NEFA levels to decrease skeletal muscle or whole body glucose utilisation during physiological hyperinsulinaemia could be explained by increased deposition of muscle glycogen, as this might compensate for decreased oxidative glucose metabolism [22, 23] . Our previous studies on this subject [23] were performed in rats fasted overnight whose muscle glycogen was partially depleted. Glycogen deposition is inhibited at high tissue glycogen concentrations [25, Table 1 . Plasma insulin and lipid levels in ad libitum fed rats and in 24 h fasted and 4.5 h fasted glucose-infused (4.5 h FGI) rats in the basal state and at the end of a hyperinsulinaemic euglycaemic clamp [27] , to examine whether, in conscious rats, when tissue glycogen levels are maintained, at or above those found in ad libitum fed rats, an elevation of plasma NEFA results in inhibition of whole body glucose utilisation at physiological insulin levels. In view of the key role of PDH in the glucose fatty acid cycle [3-6, 23, 28, 29] , the activity of this enzyme was measured in muscle, heart, liver and adipose tissue, both in the basal state and at the end of the glucose clamps.
Materials and methods

Animals
Syngeneic male Ludwig-Wistar rats were maintained on standard laboratory chow and handled daily for four weeks before study. Indwelling cannulae for metabolic studies were implanted, under ether anaesthesia, in the external jugular and femoral veins 24 h before the experiment. Insulin sensitivity was assessed by the euglycaemic clamp technique [27] , in rats weighing 280-335 g, at 4.5 or 24 h after withdrawal of food. To maintain tissue glycogen concentrations at fed levels in the 4.5 h fasted group, a 4 h i.v. infusion of 500 g/1 glucose in water (1 ml/h) was started immediately after food withdrawal at 07.00 h (4.5 h fasted, glucose infused (FGI) rats). The glucose infusion was stopped 3040 rain before the start of the glucose clamp studies to allow blood glucose concentration and insulin secretion to fall to basal levels.
Radioisotopic glucose turnover and euglycaemic clamp studies
All blood samples were taken from conscious, unrestrained animals.
After basal blood samples were taken, neutral soluble human insulin (Humulin S, Eli Lilly, B asingstoke, UK), diluted in Haemaccel, was infused at 85 mU/h for 2 h through one limb of a double lumen cannula (Miles, Stoke Poges, UK) connected to the jugular venous cannula. The insulin solution also contained 3-3H-glucose and potassium chloride, which were infused at rates of 0.12 btCi/min and 0.15 mmol/h respectively. In half of the insulin-infused rats, plasma NEFA levels were raised during the clamps by a priming bolus of heparin (10 U at 0 rain), followed by a constant infusion of heparin (40 U/h) and a 20% weight/volume triglyceride emulsion (Intralipid, Kabivitrum Ltd., Uxbridge, UK) at 0.6 ml/h, delivered through the injection port of the double lumen cannula. Blood samples for glucose (30 btl) were taken every 5-10 min and blood glucose was maintained by a variable infusion of 500 g/1 glucose in water. Blood samples were taken for insulin, triglyceride, NEFA, glycerol and 3-hydroxybutyrate estimations at 0 and 120 min (400 B1), and for glucose specific activity (200 gl) at 105 and 115 min; they were replaced with an equal volume of fresh washed rat erythrocytes in 0.15 tool/1NaC1. At + 120 min, while maintaining the clamp, rats were anaesthetised by i. v. injection of 15 mg amylobarbitone (100 g/l, Eli Lilly) and liver, heart, epididymal adipose tissue and quadriceps muscle were freeze clamped within 15 s, ground under liquid nitrogen and stored at -70~ until assayed for glycogen content and PDH activity.
Basal glucose turnover was measured in six 24 h fasted rats by a primed constant infusion of 3-3H-glucose (0.03 btCi/min). Blood samples (150 btl) were taken from the femoral venous cannula at + 50 and + 55 min for determination of plasma glucose concentration and specific activity. Tissue was removed from these animals at the end of the basal glucose turnover, and also from a group of 4.5 h fasted rats infused with glucose for 4 h after withdrawal of food (basal 4.5 h FGI rats).
For determination of glucose specific activity, plasma samples were deproteinised with Ba(OH)2/ZnSO4 as previously described [30] . Glucose turnover was calculated from the formula:
Glucose turnover = tracer infused (DPM/min) glucose specific activity (DPM/umol)
Pyruvate dehydrogenase
PDH was measured spectrophotometrically [31] , by coupling the acetyl CoA generated in the assay to p-aminophenylazobenzene sulphonic acid using arylamine acetyl transferase prepared from pigeon liver. Total PDH (PDHv) was measured after incubation of extracts with purified pig heart PDH phosphate phosphatase [31] . One unit of enzyme is defined as the amount converting I btmol/min of pyruvate to acetyl CoA at 30 ~
Other analyses
Glycogen was assayed by the amyloglucosidase method [32] . Blood for estimation of intermediary metabolites was deproteinised with perchloric acid (0.6 mol/1), and the extract was assayed for glycerol Table 2 . Glucose kinetics in the 24 h fasted and 4.5 h fasted glucose-infused (4. effect of Intralipid on clamp glucose requirement (p < 0.005) and residual hepatic glucose production (p < 0.001) and 3-hydroxybutyrate by enzymic fluorimetric methods [33] using an LS50 luminescence spectrometer (Perkin Elmer, Beaconsfield, UK). Plasma insulin was determined by radioimmunoassay [34] , using a rat or human insulin standard (Novo Industri, Bagsvaerd, Denmark) as appropriate. Blood glucose was measured by a glucose oxidase method (Yellow Springs Glucose Analyser; Clandon Scientific, London, UK). Plasma NEFA were determined with an acylCoA oxidase based color• kit (WAKO NEFA-C; Wako Chemicals GmbH, Neuss, FRG) and plasma triglyceride with a GPO-PAP kit (Boehringer, Mannheim, FRG).
Statistical analysis'
Results are presented as mean + SEM. Significant differences between groups were assessed by Student's paired or unpaired t-test or by analysis of variance as appropriate.
Results
Plasma insulin, lipid and metabolite concentrations
Steady-state plasma insulin concentrations during the glucose clamps (human insulin standard) were similar to those found in six ad lib• fed rats (rat insulin standard) and were not affected by infusion of Intralipid and heparin (Table 1) .
Thirty minutes after stopping the glucose infusion at the start of the glucose clamps, plasma NEFA, blood glycerol and 3-hydroxybutyrate concentrations were lower in the 4.5 h FGI rats than in 24 h fasted rats (all p < 0.001, Table 1 ). Whilst plasma NEFA and blood glycerol levels were higher in the 4.5 h FGI rats than in ad lib• turn fed rats (both p < 0.001), 3-hydroxybutyrate levels were not different. Plasma triglyceride, NEFA, glycerol and 3-hydroxybutyrate concentrations were suppressed during the glucose clamps and were then not different in the 4.5 h FGI and 24 h fasted rats ( Table 1) . Infusion of Intralipid and heparin during the glucose clamps resulted in an increase in plasma NEFA and triglyceride to levels which were higher than basal (Table 1) ; blood glycerol concentrations were similar to those found in rats after a 24 h fast. During the clamps with Intralipid there was incomplete suppression of 3-hydroxybutyrate concentrations in both groups of rats.
Glucose kinetics
Blood glucose concentrations during the last 30 min of the euglycaemic clamp were identical in the four groups of rats ( Table 2 ). The coefficient of variation of blood glucose calculated for each animal was 3.3 + 0.2% ( + SD). During the glucose clamp, 3-3H-glucose turnover and glucose requirement to maintain the desired blood glucose concentration were both lower in 4.5 h FGI rats than in rats fasted for 24 h (Table 2) . Hepatic glucose production during the clamp, calculated as the difference between glucose turnover and the rate of glucose infusion at steady-state, was completely suppressed and not different between the two groups ( Table 2) . When plasma lipid levels were raised during the clamps by infusion of Intralipid and heparin, there was a further 38% decrease in clamp glucose requirement in the 4.5 hFGIgroup(Table 2,p < 0.01),butnotinrats fasted for 24 h. Increased NEFA availability had no effect on 3-3H -glucose turnover in either 24 h fasted or 4.5 h FGI rats. Thus, in the 4.5 h FGI rats, increased lipid fuel availability resulted in a marked impairment of suppression of hepatic glucose output during the clamps (p < 0.001, Table 2 ).
Tissue glycogen concentrations
Quadriceps muscle glycogen concentration was partially depleted in 24 h fasted rats (Table 3 , p < 0.001). In 4.5 h FGI rats, muscle glycogen concentration was higher than in ad lib• fed rats (49.7 _+ 3.6 vs 38.1 _+ 1.7 Bmol/g wet weight, p < 0.05). Muscle glycogen deposition was stimulated by the glucose clamp in 24 h fasted rats (Table 3 , p < 0.001) but not in 4.5 h FGI rats. Intralipid enhanced muscle glycogen deposition during the clamps in both groups of rats ( Cardiac muscle glycogen concentration was higher after a 24 h fast than in ad lib• fed rats (Table 3 , p < 0.01). No stimulation of glycogen deposition by the clamp was observed in either 24 h fasted or 4.5 h FGI rats. In both groups, however, Intralipid resulted in significant stimulation of glycogen deposition during the clamp (Table 3 , p < 0.001 by ANOV). 4.5 h FGI = 4.5 h fasted rats infused with glucose for 4 h after food withdrawal; PDHT = Total PDH; PDHa% = percent of PDH in the active form. Mean _+ SEM, n = 6 in each group a p < 0.005; b p < 0.001 compared with ad libitum fed rats; by analysis of variance the increase in PDHa% from "basal" to "clamp" was significant in heart (p< 0.01) and adipose tissue (p < 0.001) d p < 0.01 compared with 24 h fasted rats in the basal state; e by analysis of variance the decrease in clamp PDHa% in the presence of Intralipid was significant in all tissues: muscle (p < 0.0l); heart, liver and adipose tissue (p < 0.001) Liver glycogen was almost completely depleted after a 24 h fast (Table 3,p < 0.001). In 24 h fasted rats there was a small increase in liver glycogen content at the end of the glucose clamp (28.0 _+ 1.7 vs 11.8 + 3.7 btmol/g wet weight, p < 0.01) and a further small increase during the clamps with Intralipid (Table 3 ,p < 0.001). In 4.5 h FGI rats, liver glycogen at the start of the glucose clamps was not different from that in ad libitum fed rats (Table 3 ). In this group liver glycogen fell during the clamp (Table 3 ,p < 0.05) but was maintained at basal levels by concomitant infusion of Intralipid and heparin (Table 3) .
Pyruvate dehydrogenase
Total PDH in muscle, heart and adipose tissue was not affected by nutritional state and did not change during the glucose clamps (Table 4 ). In liver, PDHT was lower in 4.5 h FGI rats compared to 24 h fasted rats (p < 0.001). However, liver PDHT activity relative to mitochondrial glutamate dehydrogenase was not statistically significantly different between groups (results not shown), suggesting that the lower PDHT (per g wet weight) in livers from fed rats was due to increased liver glycogen and water content in these animals.
In all four tissues the percent of PDH in the active form (PDHa%) was lower in 24 h fasted rats than in ad libitum fed rats (Table 4 ). In adipose tissue PDH~% was also lower in the 4.5 h FGI rats than in ad libitum fed rats (21.0 + 2.8 vs 50.6 + 6.8%, p < 0.005). PDHa% was increased by the hyperinsulinaemic glucose clamp in heart and adipose tissue (Table 4 , bothp < 0.001 by ANOV), but not in quadriceps skeletal muscle (Table 4 ). In liver, significant stimulation of PDHa% was seen only in 24 h fasted rats in which basal PDHa% was low. PDHa% was lower at the end of the glucose clamp in 24 h fasted rats than in the 4.5 h FGI rats in heart (F = 16.02, p < 0.002) and adipose tissue (F = 21.28, p < 0.001), but not in liver or quadriceps muscle.
When plasma NEFA and triglyceride levels were raised by concomitant infusion of Intralipid and heparin, end of clamp PDHa% was decreased markedly in all four tissues (Table 4 , all p < 0.001 by ANOV). The inhibition of PDH activation was independent of nutritional state.
Discussion
During a hyperinsulinaemic glucose clamp, skeletal muscle glycogen deposition is a major determinant of whole body glucose utilisation [27, 35] . However, high muscle glycogen levels inhibit glycogen deposition [25, 26] ; one might therefore expect insulin sensitivity to be lower in fed rats than in fasted rats. In vitro studies support this idea. The insulin sensitivity of glucose uptake by mouse soleus [36] , or perfused rat hind limb [37] , is less in the fed state. Even a short period of fasting results in depletion of tissue glycogen stores [38] and it is difficult to measure in vivo insulin sensitivity in fed animals, because a valid glucose clamp study cannot be performed if glucose is still entering the circulation from the intestine.
In the current study, one group of rats was infused with glucose for 4 h after removal of food (i. e. 4.5 h FGI rats) to maintain tissue glycogen stores whilst allowing sufficient time to complete intestinal glucose absorption before the start of the clamps. In these rats liver glycogen concentrations at the start of the clamps were the same as those of ad libitum fed animals, while their muscle glycogen concentrations were actually higher (Table 3) . Our finding of decreased whole body insulin-stimulated glucose utilisation in these 4.5 h FGI rats, compared to 24 h fasted rats (Table 2) , is in keeping with the in vitro studies mentioned above [36, 37] , but contrasts with our previous demonstration of normal rates of insulin mediated glucose utilisation in rats fasted for a similar period (3.5 h) but without glucose infusion [12] . This difference is probably explained by the higher muscle glycogen concentrations in the rats infused with glucose after removal of food. Despite high glycogen stores, the infusion of Intralipid was not associated with a further decrease in insulin-stimulated whole body glucose utilisation. These findings are in keeping with the studies of Jenkins et al. [22] , who used a similar clamp protocol in 5 h fasted rats, and with studies of Felber et al. in man [39] . The latter authors [39] employing indirect calorimetry during glucose clamp studies found lower insulin-stimulated whole body glucose utilisation and decreased glucose storage when Intralipid was infused prior to the start of a euglycaemic clamp but not when an infusion of Intralipid was started simultaneously with an infusion of insulin. They suggested that increased lipid fuel oxidation prior to the clamp prevented muscle glycogen breakdown and that the resulting higher glycogen stores inhibited insulin-mediated glycogen deposition. They did not, however, measure muscle glycogen content or rates of synthesis directly.
Assuming quadriceps muscle to be representative of most skeletal muscle, and a rat to be 40% muscle by mass~ [40] , it can be estimated that about one-third of the glucose infused during the clamp in 24 h fasted rats was deposited as muscle glycogen. Thus, the reduced muscle gly-209 cogen deposition during the glucose clamps in the 4.5 h FGI rats (Table 3) could readily explain the 20% decrease in glucose turnover observed. Contrary to expectations, the elevated basal muscle glycogen concentrations in the 4.5 h FGI rats did not prevent further muscle glycogen deposition during the clamps with Intralipid (Table 3) ; and glycogen deposition also occurred in heart; this increase in glycogen in muscle and heart when NEFA levels were elevated is consistent with the operation of the glucosefatty acid cycle in these tissues [7, 8, 23] .
In 24 h fasted rats, less than 10% of the glucose infused during the 2 h clamp was deposited as liver glycogen. With elevated plasma NEFA levels liver glycogen deposition increased approximately two-fold ( Table 3) . As little net glucose uptake by liver would occur at a blood glucose concentration of 4.0 mmol/1, enhanced liver glycogen deposition was probably due to stimulation of gluconeogenesis by increased fatty acid availability [41, 42] . By contrast with 24 h fasted rats, liver glycogen concentrations in 4.5 h FGI rats decreased by approximately 100 gmol/g during the clamp. Since hepatic glucose output was almost completely suppressed in these 4.5 h FGI rats, one must assume that the glucose-6-phosphate resulting from liver glycogen breakdown was metabolised by glycolysis to pyruvate which would then be converted to acetyl CoA by PDH. As was found by Jenkins et al. [22] in 5 h fasted rats, increasing the plasma NEFA in the 4.5 h FGI rats caused a marked impairment of suppression of hepatic glucose production ( Table 2) . Since there was no decrease in liver glycogen concentration during the clamps in these 4.5 h FGI rats given Intralipid (Table 3 ) the glucose released by the liver must have been synthesised by gluconeogenesis, implying a reversal of the flux through glycolysis/gluconeogenesis in liver because of increased lipid fuel availability. These findings are consistent with the known ability of fatty acids to stimulate gluconeogenesis [41, 42] and to inhibit glycolysis in rat hepatocytes [43] .
The stimulation of gluconeogenesis by fatty acids is generally attributed to an increase in mitochondrial acetyl CoA, and to a more reduced cytosolic redox state resulting from the generation of reducing equivalents in the mitochondria during B-oxidation of fatty acids. Acetyl CoA is an allosteric activator of the key gluconeogenic enzyme, pyruvate carboxylase [44] while NADH is required for the glyceraldehyde-3-phosphate-dehydrogenase reaction. A further mechanism involves a decrease in the concentration of hepatocyte fructose-2,6-bisphosphate (F-2,6-P2) [29, 43] , an important positive effector of phosphofructokinase-1 (PFK-1). In the current study, increased provision of glycerol (present in the Intralipid) would be expected to raise hepatocyte glycerol-3-phosphate levels. As well as representing a source of carbon for glucose synthesis, glycerol-3-phosphate inhibits PFK-2 and stimulates fructose-2,6-bisphosphatase, leading to a fall in F-2,6-P2 levels which would favour gluconeogenic flux.
The marked inhibition of hepatocyte PDHa% during the glucose clamps when circulating NEFA levels were increased, irrespective of nutritional state, is in keeping with previous studies [45] . Inactivation of PDH would be ex-pected to act in concert with the above mechanisms to promote carbon flux through gluconeogenesis. Our findings contrast with those of French et al. [29] who found no inhibition of liver PDH in ad libitum fed rats when NEFA levels were raised by administration of corn oil and heparin; these authors did, however, find an increase in PDH activity when lipolysis was inhibited in stressed animals, supporting a role for lipid oxidation in the regulation of this enzyme in liver.
It is noteworthy that insulin sensitivity was lower in the 4.5 h FGI rats than in 24 h fasted rats despite significantly increased PDH activity in heart, adipose tissue and quadriceps muscle ( Table 4) . As in liver, elevated NEFA levels during the clamps resulted in significant inhibition of PDH activity in heart, adipose tissue and quadriceps muscle, the degree of inhibition being similar in the 24 h fasted and 4.5 h FGI rats ( Table 4 ). Inhibition of PDH was not associated with any impairment of tissue glucose disposal as indicated by unchanged 3-3H-glucose turnover. Glucose metabolism was, however, qualitatively different in the presence of Intralipid. Thus, increased glycogen synthesis in muscle and heart, with unchanged glucose turnover, implies a decrease in flux through glycolysis. This is consistent with previous studies showing decreased glycolysis and pyruvate oxidation when lipid oxidation is increased [3, 6] .
Although the effects of Intralipid on glucose metabolism are generally ascribed to the direct effects of increased tissue NEFA oxidation, it remains possible that alterations in circulating levels of hormones important in the regulation of carbohydrate metabolism could contribute to the observed effects. Plasma insulin levels were not affected by Intralipid during the clamps but its influence on other hormones is unknown.
In summary, an acute elevation of plasma NEFA does not impair whole body glucose utilisation in rats during physiological hyperinsulinaemia, as increased glycogen synthesis compensates for decreased glycolytic flux. However, when liver glycogen stores are high, an acute elevation in plasma NEFA impairs insulin-mediated suppression of hepatic glucose production. This probably explains the intolerance to oral or i.v. glucose induced by concomitant lipid administration [39, [46] [47] [48] . Our findings support the idea [39, 49, 50 ] that a chronic increase in lipid availability may lead to insulin resistance by increasing tissue glycogen stores.
